abstract |
Disclosed is a pharmaceutical composition for the treatment of polypoidal choroidal vasculopathy. The following sequences: fCmGfCfCGfCmGmGfUfCfUfCmAmGmGfCGfCfUmGmAmGfUfCfUmGmAmGfUfUfUAfCfCfUmGfCmG-3T (wherein fC and fU = 2m-O ' And 3T represents inverted deoxythymidine) as an anti-C5 complement protein agent. [Selection figure] None |